Format

Send to

Choose Destination
Am J Hematol. 2019 Apr 29. doi: 10.1002/ajh.25499. [Epub ahead of print]

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease.

Author information

1
Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
2
Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Pediatric Hematology, Amsterdam, The Netherlands.
3
Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands.
4
Van Creveldkliniek, University Medical Center, University Utrecht, Utrecht, The Netherlands.
5
Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
6
Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
7
Netherlands Hemophilia Society, Leiden, The Netherlands.
8
Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Amsterdam, The Netherlands.
9
Department of Pediatric Hematology, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
10
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
11
Jon J van Rood Center for Clinical Transfusion Medicine, Sanquin Research, Leiden, The Netherlands.
12
Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
13
Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
PMID:
31037771
DOI:
10.1002/ajh.25499

Supplemental Content

Loading ...
Support Center